share_log

信立泰:关于恩那度司他新适应症获得临床试验批准通知书的公告

Shenzhen Salubris Pharmaceuticals: Announcement on the approval of clinical trial notification for new indications of Enadastron.

SZSI ·  Jul 31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more